Phibro Animal Health (NASDAQ:PAHC) Downgraded to “Hold” Rating by StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

Other equities analysts have also issued research reports about the company. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Morgan Stanley upped their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Price Performance

Shares of PAHC traded down $0.55 during trading hours on Tuesday, hitting $21.51. The stock had a trading volume of 178,902 shares, compared to its average volume of 177,985. Phibro Animal Health has a 52 week low of $12.17 and a 52 week high of $26.55. The stock has a market capitalization of $871.22 million, a price-to-earnings ratio of 44.81, a P/E/G ratio of 0.45 and a beta of 0.58. The company’s fifty day moving average is $22.74 and its two-hundred day moving average is $22.67. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, analysts anticipate that Phibro Animal Health will post 1.95 EPS for the current year.

Institutional Investors Weigh In On Phibro Animal Health

Several institutional investors have recently modified their holdings of the business. Point72 Asia Singapore Pte. Ltd. acquired a new position in Phibro Animal Health in the fourth quarter valued at approximately $29,000. Lazard Asset Management LLC raised its position in shares of Phibro Animal Health by 2,739.7% during the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company’s stock valued at $34,000 after acquiring an additional 1,589 shares during the last quarter. Quantbot Technologies LP acquired a new position in shares of Phibro Animal Health in the 3rd quarter valued at $70,000. Virtus Fund Advisers LLC bought a new position in shares of Phibro Animal Health in the 4th quarter worth $69,000. Finally, Aquatic Capital Management LLC acquired a new stake in shares of Phibro Animal Health during the fourth quarter worth $69,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.